Stemolecule™ DAPT

Catalog Size Price Quantity
04-0041 5 mg $146.00
Add To Cart
Order Offline
T: 877.228.9783
F: 617.812.5900
04-0041 Figure 1

Product Overview

Stemolecule DAPT (also known as GSI-IX or LY-374973), a cell-permeable dipeptide, inhibits γ-secretase and indirectly inhibits Notch, a γ-secretase substrate1. Since the Notch pathway is involved in the development of both the nervous system and pancreas, DAPT may be useful in modulating Notch activity in embryonic stem cell differentiation studies2. DAPT has been shown to dose-dependently decrease amyloid-β levels via inhibition of γ-secretase in both plasma and cerebral spinal fluid3. Since amyloid-β containing senile plaques are characteristic in Alzheimer's disease, DAPT may be useful in studies evaluating potential treatments for that disease.

Product Specifications


5 mg

Alternate Names

N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester

Chemical Formula


Molecular Weight


CAS Number



Greater than 99% by HPLC analysis


White Powder


For a 10 mM concentrated stock solution of DAPT, reconstitute the compound by adding 1.16 ml of DMSO to the entire contents of the vial. If precipitate is observed, warm the solution to 37°C for 2 to 5 minutes. For cell culture, the media should be prewarmed prior to adding the reconstituted compound. Note: for most cells, the maximum tolerance to DMSO is less than 0.5%. This molecule is soluble in DMSO at 100 mM.

Storage and Stability

Store powder at 4°C protected from light. Following reconstitution, store aliquots at -20°C. Stock solutions are stable for 6 months when stored as directed.

Quality Control

The purity of DAPT was determined by HPLC analysis. The accurate mass was determined by mass spectrometry. Cellular toxicity of DAPT was tested on mouse embryonic stem cells.

Specification Sheets

Safety Data Sheets


  1. Dovey, H. et al. (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76: 173-181.
  2. Crawford, T., and Roelink, H. (2007) The notch response inhibitor DAPT enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independently of sonic hedgehog signaling. Dev Dyn 236: 886-892.
  3. Lanz, T.A., Hosley, J.D., Adams, W.J., and Merchant, K.M. (2004) Studies of of A? pharmacodynamics in the brain, cererbrospinal fluid, and plasma in young (plaque-free) Tg2576 mice using the ?-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575). J Pharmacol Exp Ther. 309: 49-55.

Additional Publications

Stemgent Comments and Reviews (0)

No comments or reviews yet. Be the first to leave a review.

Add a Comment

You must log-in or register as a Stemgent member to submit a comment.

You are fully responsible for the content you post. We encourage collaboration and helpful reviews among scientists and will use this feature to conduct helpful reviews of our products. Content that includes profanity, personal attacks or antisocial behavior (such as "spamming" or "trolling"), or other inappropriate content or material will be removed. We reserve the right to block any user who violates our terms of use, including removing all content posted by that user.